mesothelioma expert

Clinical Trial Tests Drug Combination in Mesothelioma

UPDATE: Aduro Biotech announced on December 12 that they have decided to discontinue its CRS-207 clinical trial and wind down each of its trials in mesothelioma. This decision was made based on preliminary results from the trials, as well as a business and commercial assessment.
On November 8, 2017, the Meso Foundation hosted a Meet the Mesothelioma […]


NEWS: Peritoneal Surgeon Moves to Rutgers from University of Maryland

At the end of October of 2017, Dr. H. Richard Alexander, esteemed surgeon specializing in peritoneal mesothelioma, will be moving from his current institution, the University of Maryland, to Rutgers University in New Jersey.  His new position as Chief Surgical Officer will combine administrative as well as clinical duties. As such, Dr. Alexander will also […]


Mesothelioma Researcher Authors Journal Article on CAR T-cell Therapy

Mesothelioma researcher and Meso Foundation grant recipient Prasad S. Adusumilli, MD, FACS, FCCP, of the Memorial Sloan Kettering Cancer Center (MSKCC) was an author on the review article CAR T-cell therapy for lung cancer and malignant pleural mesothelioma recently published in Translational Research: The Journal of Laboratory and Clinical Medicine.
Dr. Adusumilli is a thoracic surgeon-scientist […]


“There’s no question that research cures cancer”

“There’s no question that research cures cancer,” began Dr. Rich Alexander of the University of Maryland and chair of the Meso Foundation’s Board of Directors. “If you look at the most effective therapies that we have now for many cancers across the country, those treatments were defined through the clinical trials process.”
At the 2017 International […]


Dr. Anna Nowak Selected as Recipient of the Pioneer Award

Dr. Anna Nowak, medical oncologist, is this year’s recipient of the Pioneer Award for her exceptional achievements and dedication in mesothelioma research.
The Mesothelioma Applied Research Foundation presents the award annually to thought-leaders and allies who have substantially contributed to the advancement of mesothelioma research, treatment, care, support, education, and advocacy.
The award will be presented at […]